MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Life Sciences, Medical Devices & Health Information Technology
2025: Top 10 U.S. Biopharma Clusters 2025
New Jersey
*Industry: New Jersey
OncoSec Medical Incorporated (NASDAQ: ONCS)
Organization & Developments: OncoSec
Parents
OncoSec Medical Incorporated (NASDAQ: ONCS)
Children
2018: OncoSec Medical: An Enticing Speculation_seekingalpha.com
2019: OncoSec's Licensing Of CAR-T Tech For Solid Tumors Opens Up A New Door For The Future_seekingalpha.com
2022: Oncosec Sheds 45% of staff to fund IL-12 drug through Keytruda combo trial
Developing a proprietary electroporation delivery technology that is intended to make cancer cells more vulnerable to chemotherapeutic or novel DNA-based immunotherapeutics.
Develops novel cancer therapeutic products that combine its proprietary electroporation delivery technology with a chemotherapeutic or novel DNA-based immunotherapeutics.
University of Washington (UW) will join UC San Francisco, the John Wayne Cancer Institute, and Lakeland Cancer Center as the fourth site for its mid-stage metastatic melanoma clinical trial
Jumps
*Key People: OncoSec
Finance & Acquisition: OncoSec